Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors

European Journal of Endocrinology

Volumn 142, Issue 6, 2000, Pages 689-695

  Zwermann, O ^c   Beuschlein, F ^c   Mora, P ^c   Weber, G ^a   Allolio, B ^c   Reincke, M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX TUMOR; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL;

EID: 0034046728     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420689     Document Type: Article

References (39)

1. Skogseid B, Larsson C, Lindgren PG, Kvanta E, Rastad J, Theodorsson E et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. Journal of Clinical Endocrinology and Metabolism 1992 75 76-81.
2. Beckers A, Abs R, Willems P, Van der Auwera B, Kovacs K, Reznik M et al., Aldosterone secreting adrenal adenoma as part of multiple endocrine neoplasia type1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. Journal of Clinical Endocrinology and Metabolism 1992 75 564-570.
3. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997 276 404-407.
4. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Human Molecular Genetics 1997 6 1177-1183.
5. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC et al. Somatic mutation of the MEN1 gene in parathyroid tumours. Nature Genetics 1997 16 375-578.
6. Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A, White I et al. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Human Genetics 1997 99 324-349.
7. Farnebo F, Teh BT, Kytölä S, Svensson A, Phelan C, Sandelin K et al. Alteration of the MEN1 gene in sporadic parathyroid tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 2627-2630.
8. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park WS et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Research 1997 57 5446-5451.
9. Tanaka C, Kimura T, Yang P, Moritani M, Yamaoka T, Yamada S et al. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1998 83 2631-2634.
10. Prezant TR. Levine J & Melmed S. Molecular characterization of the MEN1 tumor suppressor gene in sporadic pituitary tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 1388-1391.
11. Poncin J, Stevenaert A & Beckers A. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. European Journal of Endocrinology 1999 140 573-576.
12. Debelenko LV, Zhuang Z, Emmert-Buck MR, Moritani M, Yamaoka T, Yamada S et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Research 1997 57 2238-2243.
13. Hessman O, Lindberg D. Skogseid B, Carling T, Hellmann P, Rastad J et al. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial. malignant tumors of the endocrine pancreas. Cancer Research 1998 58 577-379.
14. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Research 1997 57 4682-4686.
15. Iida A, Blake K, Tunny T, Klemm S, Stowasser M, Hayward N et al. Allelic losses on chromosome band 11q13 in aldosterone producing adrenal tumors. Genes, Chromosomes and Cancer 1995 12 73-75.
16. Debelenko L, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Human Molecular Genetics 1997 6 2285-2290.
17. Heppner Ch, Reincke M, Agerwal SK, Mora P, Allolio B, Burns AL et al. MEN1 Gene analysis in sporadic adrenocortical neoplasms. Journal of Clinical Endocrinology and Metabolism 1999 84 216-219.
18. Courseaux A, Grosgeorge J, Gaudray P, Pannett AA, Forbes SA, Williamson C et al. Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1 (GENEM 1; Groupe d'Etude des Neoplasies Endocriniennes Multiples de type 1). Genomics 1996 37 354-365
19. Koetsier PA, Schorr J & Doerfler W. A rapid optimized protocol for downward alkaline Southern blotting of DNA. BioTechiques 1993 15 260-262.
20. Weber G, Friedman E, Grimmond S, Hayward NK, Phelan C, Skogseid B et al. The phospholipase Cβ3 gene located at the MEN1 region shows loss of expression in endocrine tumors. Human Molecular Genetics 1994 3 1775-1781.
21. Larsson C, Calendar A, Grimmond S, Giraud S, Hayward NK, Teh B et al. Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. Journal of Internal Medicine 1995 238 239-244.
22. Manickam P, Guru SC, Debelenko LV, Agarwal SK, Olufemi SE, Weisemann JM et al. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Human Genetics 1997 101 102-108.
23. Guru SC, Goldsmith PK, Burns AL, Marx S, Spiegel A, Collins F et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proceedings of the National Academy of Sciences of the USA 1998 95 1630-1634.
24. Huang SC, Zhuang Z, Weil RJ, Pack S, Wang C, Krutzsch H et al. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Laboratory Investigation 1999 79 301-310.
25. Agarwal SK, Guru SC, Heppner C, Erdos M, Collins R, Park S et al. Menin interacts with the API transcription factor JunD and represses JunD-activated transcription. Cell 1999 96 143-152.
26. Chanson P, Cadiot G & Mural A. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples de type 1. Hormone Research 1997 47 211-220.
27. Burgess JR, Harle RA, Tucker P, Parameswaran V, Davies P, Greenaway TM et al. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Archives of Surgery 1996 131 699-702.
28. Skogseid B, Rastad J, Gobi A, Larsson C, Backlin K, Juhlin C et al. Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 1995 118 1077-1082.
29. Kjellman M, Roshani L, The BT, Kallioniemi OP, Hoog A, Gray S et al. Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. Journal of Clinical Endocrinology and Metabolism 1999 84 750-735.
30. Görtz B, Roth J, Speel EJM, Krahenmann A, De Krijger RR, Matias-Guiu X et al. MEN1 Gene mutation analysis of sporadic adrenocortical lesions. International Journal of Cancer 1999 80 373-379.
31. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the USA 1971 68 820-823.
32. Kjellman M, Kalljonieuni OP, Karhu R, Hoog A, Farnebo LO, Auer G et al. Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Research 1996 15 4219-4223.
33. Lagercrantz J, Carson E, Phelan C, Grimmond S, Rosén A, Daré E et al. Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase Cβ3 gene (PLCB3). Genomics 1995 26 467-472.
34. Lagercrantz J, Larsson C, Grimmond S, Skogseid B, Gobl A, Friedman E et al. Candidate genes for multiple endocrine neoplasia type 1. Journal of Internal Medicine 1995 238 245-248.
35. Weber G, Grimmond S, Lagercrantz J, Friedman E, Phelan C, Carson E et al. Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCB3) gene as candidate for multiple endocrine neoplasia type 1. Human Genetics 1997 99 130-132.
36. de Wit MJ, Landsvater RM, Sinke RJ, Geurts van Kessel A, Lips CJ, Hoppener JW et al. Exclusion of the phosphatidylinositol-specific phospholipase Cβ3 (PLCB3) gene as candidate for multiple endocrine neoplasia type 1. Human Genetics 1997 99 133-137.
37. Chakrabarti R, Srivatsan ES, Woods TE, Eubanks PJ, Ebrahimi SA, Gatti RA et al. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome 11q13. Genes, Chromosomes and Cancer 1998 22 130-137.
38. Asa SL, Somers K & Ezzat S. The MEN-1 Gene is rarely down-regulated in pituitary tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 3210-3212.
39. Farrell WE, Simpson DJ, Bicknell J, Magnay JL, Kyrodimou E, Thakker RV et al. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours. British Journal of Cancer 1999 80 44-50.